Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - COMMON STOCK
Common Stock DNLI - Denali Therapeutics Inc.
1.71 M
LAST VALUE
5.13%
2 YEAR CAGR
6.09%
5 YEAR CAGR
0.00%
10 YEAR CAGR